A clinical trial to study the efect of the drug Pirandai vadagam in patients having ulcer pain in the stomach

A clinical study on Eri Gunmam (Peptic Ulcer) with the evaluation of Siddha drug Pirandai Vadagam

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008486

Enrollment

Registered

2017-05-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Eri Gunmam (Peptic Ulcer)

Interventions

Intervention1: Pirandai Vadagam: 1 gram of Pirandai vadagam is administered twice a day with water for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Epigastric Pain and burning with relation of food 2.Anorexia 3.Bloating and fullness of the stomach Diarrhoea

Exclusion criteria

Exclusion criteria: 1.Known H/O Pyloric stenosis 2.Known H/O CA in stomach 3.Known H/O of Acute abdominal colic 4.Known H/O Cholelithiasis, Pancreatitis 5.Known H/O Ulcer perforation and Gastric Obstruction

Design outcomes

Primary

Measure	Time frame
Outcome is mainly assessed by reduction in clinical symptoms and by comparing the Endoscopic examination before and after treatmentTimepoint: 48 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr G Anitha Therese

Govt Siddha Medical College

drkkanakavalli@gmail.com9444122865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026